TR199902455T2 - 5,7-Dis�bstit�e 4-Aminopirido (2,3-D) Pirimidin bile�ikleri ve bunlar�n adenosin kinaz inhibit�rleri olarak kullan�m� - Google Patents

5,7-Dis�bstit�e 4-Aminopirido (2,3-D) Pirimidin bile�ikleri ve bunlar�n adenosin kinaz inhibit�rleri olarak kullan�m�

Info

Publication number
TR199902455T2
TR199902455T2 TR1999/02455T TR9902455T TR199902455T2 TR 199902455 T2 TR199902455 T2 TR 199902455T2 TR 1999/02455 T TR1999/02455 T TR 1999/02455T TR 9902455 T TR9902455 T TR 9902455T TR 199902455 T2 TR199902455 T2 TR 199902455T2
Authority
TR
Turkey
Prior art keywords
adenosine kinase
compound
disebictie
aminopyrido
kinase inhibitors
Prior art date
Application number
TR1999/02455T
Other languages
English (en)
Turkish (tr)
Inventor
S.Bhagwat Shripad
Lee Chih-Hung
D. Cowart Marlon
Mckie Jeffrey
Laure Grillot Anne
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of TR199902455T2 publication Critical patent/TR199902455T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TR1999/02455T 1997-04-16 1998-04-14 5,7-Dis�bstit�e 4-Aminopirido (2,3-D) Pirimidin bile�ikleri ve bunlar�n adenosin kinaz inhibit�rleri olarak kullan�m� TR199902455T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83821697A 1997-04-16 1997-04-16

Publications (1)

Publication Number Publication Date
TR199902455T2 true TR199902455T2 (xx) 2000-01-21

Family

ID=25276561

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02455T TR199902455T2 (xx) 1997-04-16 1998-04-14 5,7-Dis�bstit�e 4-Aminopirido (2,3-D) Pirimidin bile�ikleri ve bunlar�n adenosin kinaz inhibit�rleri olarak kullan�m�

Country Status (18)

Country Link
EP (1) EP0989986A1 (xx)
JP (1) JP2001520655A (xx)
KR (1) KR20010006509A (xx)
CN (1) CN1252070A (xx)
AR (1) AR012436A1 (xx)
AU (1) AU7108398A (xx)
BG (1) BG103842A (xx)
BR (1) BR9809055A (xx)
CA (1) CA2286909A1 (xx)
CO (1) CO4940446A1 (xx)
HU (1) HUP0001434A3 (xx)
IL (1) IL131618A0 (xx)
NO (1) NO995036L (xx)
PL (1) PL336304A1 (xx)
SK (1) SK141799A3 (xx)
TR (1) TR199902455T2 (xx)
WO (1) WO1998046605A1 (xx)
ZA (1) ZA983177B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000023444A1 (en) * 1998-10-21 2000-04-27 Abbott Laboratories 5,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
IL156872A0 (en) 2001-02-12 2004-02-08 Hoffmann La Roche 6-substituted pyrido-pyrimidines
MXPA04006882A (es) 2002-01-17 2004-12-06 Neurogen Corp Analogos substituidos de quinazolin-4-ilamina como moduladores de receptores de capsaicina.
DE10335183A1 (de) * 2003-07-30 2005-02-24 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
ATE449097T1 (de) * 2005-07-21 2009-12-15 Hoffmann La Roche Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer
AU2006330924B2 (en) * 2005-12-21 2012-03-15 Abbvie Inc. Anti-viral compounds
ES2395386T3 (es) 2005-12-21 2013-02-12 Abbott Laboratories Compuestos antivirales
EP2094276A4 (en) 2006-12-20 2011-01-05 Abbott Lab ANTIVIRAL COMPOUNDS
MX2010002258A (es) 2007-08-27 2010-04-22 Helicon Therapeutics Inc Compuestos terapeuticos de isoxazol.
EP2559693B1 (en) 2007-08-31 2014-11-26 Eisai R&D Management Co., Ltd. Polycyclic compound
DE102007061764A1 (de) * 2007-12-20 2009-06-25 Bayer Healthcare Ag Anellierte Cyanopyridine und ihre Verwendung
WO2010098487A1 (en) * 2009-02-26 2010-09-02 Eisai R&D Management Co., Ltd. Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
WO2014055595A1 (en) 2012-10-05 2014-04-10 Merck Sharp & Dohme Corp. Indoline compounds as aldosterone synthase inhibitiors related applications
KR102514814B1 (ko) 2016-03-31 2023-03-27 온크터널 테라퓨틱스, 인코포레이티드. 인돌린 유사체 및 이의 용도
CN110256420B (zh) * 2019-05-07 2020-04-28 江西中医药大学 四氢吡啶并嘧啶衍生物及其制备方法和用途
CN110283171A (zh) * 2019-07-17 2019-09-27 鼎泰(南京)临床医学研究有限公司 一类含有吡啶并嘧啶-4-胺类结构的化合物、药物组合物以及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324731A (en) * 1989-02-14 1994-06-28 Amira, Inc. Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
US6143749A (en) * 1995-06-07 2000-11-07 Abbott Laboratories Heterocyclic substituted cyclopentane compounds

Also Published As

Publication number Publication date
JP2001520655A (ja) 2001-10-30
HUP0001434A2 (hu) 2000-10-28
NO995036D0 (no) 1999-10-15
WO1998046605A1 (en) 1998-10-22
CO4940446A1 (es) 2000-07-24
BG103842A (en) 2000-06-30
ZA983177B (en) 1999-01-22
EP0989986A1 (en) 2000-04-05
CA2286909A1 (en) 1998-10-22
AU7108398A (en) 1998-11-11
CN1252070A (zh) 2000-05-03
IL131618A0 (en) 2001-01-28
AR012436A1 (es) 2000-10-18
SK141799A3 (en) 2000-08-14
PL336304A1 (en) 2000-06-19
BR9809055A (pt) 2000-08-08
NO995036L (no) 1999-10-15
KR20010006509A (ko) 2001-01-26
HUP0001434A3 (en) 2001-01-29

Similar Documents

Publication Publication Date Title
TR199902455T2 (xx) 5,7-Dis�bstit�e 4-Aminopirido (2,3-D) Pirimidin bile�ikleri ve bunlar�n adenosin kinaz inhibit�rleri olarak kullan�m�
TR200002617T2 (tr) Aril ve heteroaril sübstitüentli heterosiklik üreler kullanılarak RAF kinazın inhibe edilmesi
TR200200749T2 (tr) Kinazolin bileşikleri ve bunları içeren farmasötik bileşikler.
TR199801115T2 (xx) Kinazolin t�revleri.
BR0014136A (pt) Composto, uso do mesmo, métodos para a preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica
TR200100047T2 (tr) Tiyobenzimidazol türevleri
RU2694252C3 (ru) Производные 4-(замещенного фениламино)хиназолина или их фармацевтически приемлемые соли, способ ингибирования рецепторной тирозинкиназы и фармацевтическая композиция
TR199900827T2 (xx) Siklooksigenaz-2 inhibit�rlerinin neoplazinin tedavisinde ve �nlenmesinde kullan�m�.
AP2001002088A0 (en) 4,4-Biarylpiperidine derivatives with opiod receptor activity.
TR199901578T2 (xx) Klaritromisin form 0 kristali
GEP20053424B (en) Pyrimidine-2,4,6-Trione Metalloproteinase Inhibitors
NO984470L (no) Pyrrolopyrrolon-derivater som inhibitorer for neutrofil elastase
HUP0003982A3 (en) The use of inhibitors of the renin-angiotensin system for producing pharmaceutical compositions using for the treatment of hypoxia or impaired metabolic function
ATE269865T1 (de) Pyrazolo(3,4-g)chinoxaline als pdgf-rezeptor protein tyrosin-kinase inhibitoren
CA2219359A1 (en) Hydantoin derivatives as intermediates for pharmaceutical active compounds
ES2184318T3 (es) 6-alquilfenantridinas sustituidas.
HK1041264A1 (en) Imidazole compounds and their use as adenosine deaminase inhibitors
BRPI0207102A8 (pt) forma cristalina, composição farmacêutica, e, uso de uma forma cristalina.
IS4725A (is) Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasa
TR199902456T2 (xx) 6,7-ikameli-4-aminopirido$2,3,-D]Pirimidin bile�ikleri.
AR035909A1 (es) Esteres de derivados de adenosina n6-oxa, -tia, -tioxa, y azacicloalquilo sustituidos, composicion farmaceutica que los comprende y el uso de dichos derivados para la manufactura de un medicamento
TR199902550T2 (xx) 5, 6, 7-Tris�bstit�e -4-aminopirido $2,3-D] pirimidin bile�ikleri.
BG105862A (en) Light, extruded compositions containing a light, extrudable, ceramic carrier, methods for their use and preparartion
TR200003572T2 (tr) Siyanoiminokuinoksalin Türevleri
NO996496L (no) (S) 2-metylamino-2-fenyl-n-butyl 3,4,5-trimetoksybenzoat samt anvendelse av denne ved behandling av kronisk smerte